A protein called OGDHL slowed glioblastoma growth in lab and mouse tests
Original title: Integrated multi-omics and machine learning identify OGDHL as a key regulator of glioblastoma progression and antitumor immunity via glutamine metabolism and histone lactylation.
How far along is this research?
- Lab cells
- Animals
- Review
- Tested in people
This was done in animals, not people. Most findings at this stage never become treatments.
This was only done in lab cells and in mice, not in people.
The short version
Researchers found a protein that, when boosted, made brain tumor cells grow slower and easier for the immune system to attack.
What was studied. Scientists searched large sets of gene and protein data to find proteins that matter in glioblastoma: The fastest-growing type of glioma (grade 4). Treatment usually starts soon after diagnosis: surgery first, then radiation and chemotherapy. See the glossary. They picked one called OGDHL and tested it in tumor cells in the lab and in mice.
What they found. OGDHL levels were low in glioblastoma: The fastest-growing type of glioma (grade 4). Treatment usually starts soon after diagnosis: surgery first, then radiation and chemotherapy. See the glossary tissue and in lower grade glioma: A tumor that starts in the glial cells, the support cells of the brain and spinal cord. Gliomas are graded 1 to 4 by how fast they tend to grow. See the glossary tissue. When the team raised OGDHL in tumor cells, the cells grew less and more of them died. The cells also made less lactate and less PD-L1, a signal tumors use to hide from the immune system. Immune cells called CD8+ T cells then killed the tumor cells better. In mice, raising OGDHL slowed tumor growth.
What this means, and what it doesn't
What it could mean: This points to a possible new target for future glioblastoma: The fastest-growing type of glioma (grade 4). Treatment usually starts soon after diagnosis: surgery first, then radiation and chemotherapy. See the glossary drugs. It suggests that changing how tumor cells use fuel may also help the immune system fight them. For now it is a lead for researchers to follow.
What it doesn't mean: This does not mean there is a new treatment. The work was done in cells in a dish and in mice, not in people. No one has shown it is safe or helpful for patients. It is not a cure, and it is many years and many trials away from everyday care. Nothing here changes the treatment you and your doctor are discussing now.
Source: PubMed, August 1, 2026 · Read the original
This plain-language summary was written by AI and published automatically after passing our automatic safety checks. How we write.